8.54BMarket Cap
22.15P/E TTM
Qiagen NV's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Qiagen NV is 7.22, ranking 196 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 22.15, which is 480.06% below the recent high of 128.51 and 21.76% above the recent low of 17.33.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.